XML 67 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Sep. 29, 2012
Oct. 01, 2011
Oct. 02, 2010
Cash Flows From Operating Activities:      
Net earnings (loss) $ 1,809,000 $ (387,000) $ 473,000
Earnings from discontinued operations     (15,000)
Earnings (loss) from continuing operations 1,809,000 (387,000) 458,000
Adjustments to reconcile earnings (loss) from continuing operations to net cash provided by (used for) operating activities of continuing operations:      
Depreciation and amortization 9,762,000 9,573,000 7,009,000
Amortization of capitalized financing costs 97,000 81,000 363,000
Stock-based compensation expense 2,208,000 2,917,000 2,258,000
Gain on early extinguishment of debt (425,000)    
Asset impairment charges (11,000) 3,825,000  
Inventory write-downs     2,333,000
Excess tax deficiencies (benefits) from stock-based compensation   (8,000) 89,000
Loss (gain) on sale of property, plant and equipment (46,000) (1,618,000) 39,000
Deferred income taxes 835,000 209,000 (1,121,000)
Gain from life insurance proceeds (505,000) (357,000)  
Increase in cash surrender value of life insurance policies over premiums paid (750,000)   (330,000)
Net changes in assets and liabilities (net of assets and liabilities acquired):      
Accounts receivable, net (167,000) (17,001,000) (3,687,000)
Inventories 10,600,000 (11,870,000) (7,710,000)
Accounts payable and accrued expenses (9,562,000) 12,439,000 (2,489,000)
Other changes (701,000) (710,000) 15,825,000
Total adjustments 11,335,000 (2,520,000) 12,579,000
Net cash provided by (used for) operating activities - continuing operations 13,144,000 (2,907,000) 13,037,000
Net cash used for operating activities - discontinued operations     (158,000)
Net cash provided by (used for) operating activities 13,144,000 (2,907,000) 12,879,000
Cash Flows From Investing Activities:      
Capital expenditures (8,066,000) (7,937,000) (1,493,000)
Increase in cash surrender value of life insurance policies (467,000) (147,000) (456,000)
Proceeds from surrender of life insurance policies 37,000 19,000  
Proceeds from sale of property, plant and equipment 305,000 518,000 11,000
Proceeds from sale of assets held for sale   2,403,000  
Proceeds from life insurance claims   1,063,000  
Acquisition of business   (37,308,000)  
Net cash used for investing activities - continuing operations (8,191,000) (41,389,000) (1,938,000)
Net cash provided by investing activities - discontinued operations     2,358,000
Net cash provided by (used for) investing activities (8,191,000) (41,389,000) 420,000
Cash Flows From Financing Activities:      
Proceeds from long-term debt 91,150,000 52,806,000 338,000
Principal payments on long-term debt (93,406,000) (52,150,000) (338,000)
Cash dividends paid (2,121,000) (2,112,000) (2,108,000)
Financing costs (172,000)   (409,000)
Cash received from exercise of stock options 2,000 21,000 140,000
Excess tax benefits (deficiencies) from stock-based compensation   8,000 (89,000)
Other (406,000) (202,000)  
Net cash used for financing activities - continuing operations (4,953,000) (1,629,000) (2,466,000)
Net cash used for financing activities (4,953,000) (1,629,000) (2,466,000)
Net increase (decrease) in cash and cash equivalents   (45,925,000) 10,833,000
Cash and cash equivalents at beginning of period 10,000 45,935,000 35,102,000
Cash and cash equivalents at end of period 10,000 10,000 45,935,000
Cash paid (refunded) during the period for:      
Interest 753,000 356,000 90,000
Income taxes, net 176,000 (489,000) 189,000
Non-cash investing and financing activities:      
Purchases of property, plant and equipment in accounts payable 176,000 384,000 15,000
Restricted stock surrendered for withholding taxes payable 446,000 143,000 79,000
Note payable issued as consideration for business acquired   13,500,000  
Post-closing purchase price adjustment for business acquired   $ 500,000